51,353-share RSU grant to Strata Critical (SRTA) executive Scott Wunsch

Rhea-AI Filing Summary

Wunsch Scott M reported acquisition or exercise transactions in this Form 4 filing.

Strata Critical Medical, Inc. reported that Scott M. Wunsch, CEO of Trinity Air Medical, received a grant of 51,353 restricted stock units of Class A common stock at no cost. These RSUs vest 6.25% every three months after March 8, 2026, with remaining units vesting on March 8, 2030, contingent on continued service. Following this award, he holds 573,438 shares directly and 382,987 shares indirectly through a limited liability company of which he is the sole member.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wunsch Scott M

(Last) (First) (Middle)

C/O STRATA CRITICAL MEDICAL, INC.

31 HUDSON YARDS, 14TH FLOOR

(Street)

NEW YORK NY 10001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Strata Critical Medical, Inc. [ SRTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, Trinity Air Medical

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A common stock, $0.0001 par value per share	02/24/2026		A		51,353(1)	A	$0	573,438	D
Class A common stock, $0.0001 par value per share								382,987	I(2)	See Footnotes

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting: 6.25% of the RSUs (rounded down to the nearest whole number) will vest every 3 months after March 8, 2026, with any remaining unvested RSUs to vest on March 8, 2030, subject to the Reporting Person's continued service to the Issuer.

2. Held directly by a limited liability company of which the Reporting Person is the sole member.

Remarks:

	/s/ Melissa M. Tomkiel, Attorney-in-fact for Scott M. Wunsch	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Strata Critical Medical (SRTA) report for Scott M. Wunsch?

Strata Critical Medical reported that Scott M. Wunsch received 51,353 restricted stock units of Class A common stock as a grant. The units were awarded at no cost and will settle in shares upon vesting over several years.

How do the new RSUs granted to Scott M. Wunsch at Strata Critical Medical (SRTA) vest?

The 51,353 RSUs granted to Scott M. Wunsch vest 6.25% every three months after March 8, 2026. Any remaining unvested RSUs will vest on March 8, 2030, provided he continues to serve the company during this period.

How many Strata Critical Medical (SRTA) shares does Scott M. Wunsch hold after this Form 4?

After the reported grant, Scott M. Wunsch holds 573,438 shares of Class A common stock directly. He also has 382,987 shares reported as indirectly owned, giving him substantial equity exposure to Strata Critical Medical’s performance.

What does the indirect ownership reported for Scott M. Wunsch in Strata Critical Medical (SRTA) mean?

The indirect holdings are held by a limited liability company of which Scott M. Wunsch is the sole member. This structure means the shares are owned through the LLC rather than in his personal name, but still reflect his economic interest.

Was Scott M. Wunsch’s recent Strata Critical Medical (SRTA) stock grant a market purchase?

No, the 51,353 units reported were granted as restricted stock units at a price of $0.0000 per share. This indicates a compensatory award rather than an open market purchase of Strata Critical Medical stock.

What security class is involved in Scott M. Wunsch’s Form 4 for Strata Critical Medical (SRTA)?

The Form 4 involves Strata Critical Medical’s Class A common stock with a par value of $0.0001 per share. The grant consists of restricted stock units that will settle in this same class of common stock when they vest.